{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:18:33Z","timestamp":1790965113012,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1124\/mol.113.086470","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T04:07:35Z","timestamp":1365566855000},"page":"1268-1275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Therapeutic Cleavage of Anti\u2013Aquaporin-4 Autoantibody in Neuromyelitis Optica by an IgG-Selective Proteinase"],"prefix":"10.1016","volume":"83","author":[{"given":"Lukmanee","family":"Tradtrantip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithi","family":"Asavapanumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.113.086470_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/381982","article-title":"Low antibody levels against cell wall-attached proteins of Streptococcus pyogenes predispose for severe invasive disease","volume":"189","author":"Akesson","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1124\/mol.113.086470_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.113.086470_bib3","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/emboj\/20.12.3046","article-title":"EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG","volume":"20","author":"Collin","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/mol.113.086470_bib4","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1128\/IAI.69.11.7187-7189.2001","article-title":"Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins","volume":"69","author":"Collin","year":"2001","journal-title":"Infect Immun"},{"key":"10.1124\/mol.113.086470_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1756285611398939","article-title":"Current and future treatment approaches for neuromyelitis optica","volume":"4","author":"Collongues","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1124\/mol.113.086470_bib6","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","article-title":"Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1\/M23 isoforms and orthogonal arrays","volume":"286","author":"Crane","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.113.086470_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-008-0066-2","article-title":"Neuromyelitis optica: diagnosis, pathogenesis, and treatment","volume":"8","author":"Cree","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1124\/mol.113.086470_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1124\/mol.113.086470_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1124\/mol.113.086470_bib10","doi-asserted-by":"crossref","first-page":"e1692","DOI":"10.1371\/journal.pone.0001692","article-title":"IdeS: a bacterial proteolytic enzyme with therapeutic potential","volume":"3","author":"Johansson","year":"2008","journal-title":"PLoS one"},{"key":"10.1124\/mol.113.086470_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3988\/jcn.2013.9.1.36","article-title":"Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels","volume":"9","author":"Kim","year":"2013","journal-title":"J Clin Neurol"},{"key":"10.1124\/mol.113.086470_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2011.08.043","article-title":"Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders","volume":"311","author":"Kira","year":"2011","journal-title":"J Neurol Sci"},{"key":"10.1124\/mol.113.086470_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1124\/mol.113.086470_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1124\/mol.113.086470_bib15","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1124\/mol.113.086470_bib16","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/art.22930","article-title":"Blocking of experimental arthritis by cleavage of IgG antibodies in vivo","volume":"56","author":"Nandakumar","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1124\/mol.113.086470_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":"Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain","volume":"17","author":"Nielsen","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/mol.113.086470_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1124\/mol.113.086470_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/mol.113.086470_bib20","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","article-title":"Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays","volume":"287","author":"Phuan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.113.086470_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1124\/mol.113.086470_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ana.22686","article-title":"Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain","volume":"71","author":"Saadoun","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.113.086470_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0004-282X2012000100012","article-title":"Treatment of neuromyelitis optica: an evidence based review","volume":"70","author":"Sato","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1124\/mol.113.086470_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ana.23741","article-title":"Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody","volume":"73","author":"Tradtrantip","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.113.086470_bib25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1096\/fj.11-201608","article-title":"Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica","volume":"26","author":"Tradtrantip","year":"2012","journal-title":"FASEB J"},{"key":"10.1124\/mol.113.086470_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica","volume":"71","author":"Tradtrantip","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1124\/mol.113.086470_bib27","doi-asserted-by":"crossref","first-page":"15540","DOI":"10.1021\/bi048284d","article-title":"Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding","volume":"43","author":"Vincents","year":"2004","journal-title":"Biochemistry"},{"key":"10.1124\/mol.113.086470_bib28","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/emboj\/21.7.1607","article-title":"IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G","volume":"21","author":"von Pawel-Rammingen","year":"2002","journal-title":"EMBO J"},{"key":"10.1124\/mol.113.086470_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1124\/mol.113.086470_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1124\/mol.113.086470_bib31","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/ndt\/gfq115","article-title":"Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes","volume":"25","author":"Yang","year":"2010","journal-title":"Nephrol Dial Transplant"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24037301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24037301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.113.086470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:14:28Z","timestamp":1739963668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24037301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0026895X24037301"],"URL":"https:\/\/doi.org\/10.1124\/mol.113.086470","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Cleavage of Anti\u2013Aquaporin-4 Autoantibody in Neuromyelitis Optica by an IgG-Selective Proteinase","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.113.086470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}